Walter Weder

28.1k total citations · 5 hit papers
434 papers, 15.4k citations indexed

About

Walter Weder is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Walter Weder has authored 434 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Pulmonary and Respiratory Medicine, 161 papers in Surgery and 85 papers in Oncology. Recurrent topics in Walter Weder's work include Transplantation: Methods and Outcomes (108 papers), Pleural and Pulmonary Diseases (101 papers) and Occupational and environmental lung diseases (77 papers). Walter Weder is often cited by papers focused on Transplantation: Methods and Outcomes (108 papers), Pleural and Pulmonary Diseases (101 papers) and Occupational and environmental lung diseases (77 papers). Walter Weder collaborates with scholars based in Switzerland, United States and Belgium. Walter Weder's co-authors include Didier Lardinois, Rolf A. Stahel, Sven Hillinger, İlhan İnci, Isabelle Opitz, Erich W. Russi, Hans C. Steinert, Stephan Korom, Gustav K. von Schulthess and Rudolf Speich and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Walter Weder

419 papers receiving 15.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed Tomography

2003 1.1k citations Walter Weder et al. profile →
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer

2014 521 citations Bernward Passlick, Walter Weder et al. European Journal of Cardio-Thoracic Surgery profile →
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2010 424 citations Walter Weder et al. profile →
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

2009 420 citations Hendrik Dienemann, Rolf A. Stahel et al. European Respiratory Journal profile →
Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer

2021 222 citations Walter Weder et al. profile →

Peers

Walter Weder

PRM

SURGE

ONCOL

RNMI

Hiroshi Date Japan

Larry R. Kaiser United States

Hartwig Huland Germany

James D. Luketich United States

Kazuhiro Yasufuku Canada

Antoon Lerut Belgium

Ulf P. Neumann Germany

Karl‐Walter Jauch Germany

Theodore L. Phillips United States

Meinoshin Okumura Japan

Hiroshi Date Japan

Walter Weder

9.0k ×0.9

PRM

4.8k ×1.2

SURGE

4.2k ×1.4

ONCOL

966 ×0.4

RNMI

2.5k ×1.7

Citations per year, relative to Walter Weder Walter Weder (= 1×) peers Hiroshi Date

Countries citing papers authored by Walter Weder

Since Specialization

Citations

This map shows the geographic impact of Walter Weder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Weder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Weder more than expected).

Fields of papers citing papers by Walter Weder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Weder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Weder. The network helps show where Walter Weder may publish in the future.

Co-authorship network of co-authors of Walter Weder

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Weder. A scholar is included among the top collaborators of Walter Weder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Weder. Walter Weder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Furrer, Katarzyna, Daniel P. Dolan, Alessandra Curioni‐Fontecedro, et al.. (2021). Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes. European Journal of Cardio-Thoracic Surgery. 60(6). 1297–1305. 12 indexed citations

Oehl, Kathrin, Bart Vrugt, Ulrich Wagner, et al.. (2021). Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma. Clinical Cancer Research. 27(8). 2277–2291. 30 indexed citations

Caviezel, Claudio, Henrik Jessen Hansen, Michael Perch, et al.. (2020). Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves. Interactive Cardiovascular and Thoracic Surgery. 32(2). 263–269. 5 indexed citations

Meulen‐Muileman, Ida H. van der, Renée X. de Menezes, Kathrin Oehl, et al.. (2019). Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition. Molecular Cancer Therapeutics. 19(2). 552–563. 18 indexed citations

Stamatis, Georgios, Gunda Leschber, Claudia Ose, et al.. (2019). Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system). Lung Cancer. 138. 19–26. 50 indexed citations

Lauk, Olivia, Miriam Patella, Martina Friess, et al.. (2019). Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 2 indexed citations

Lara, Paulino Tallón de, Virginia Cecconi, Stefanie Hiltbrunner, et al.. (2018). Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients. Clinical Cancer Research. 24(24). 6345–6354. 44 indexed citations

Casanova, Ruben, Daniel Xia, Paolo Nanni, et al.. (2017). Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness. Cancer Research. 77(10). 2585–2593. 10 indexed citations

Klikovits, Thomas, Paul Stockhammer, Viktória László, et al.. (2017). Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma. Scientific Reports. 7(1). 16456–16456. 20 indexed citations

10.

Meerang, Mayura, Emanuela Felley‐Bosco, Olivia Lauk, et al.. (2016). Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma. Molecular Cancer Therapeutics. 15(5). 1095–1105. 21 indexed citations

11.

Frauenfelder, Thomas, Milo A. Puhan, Romain Lazor, et al.. (2014). Early Detection of Lung Cancer: A Statement from an Expert Panel of the Swiss University Hospitals on Lung Cancer Screening. Respiration. 87(3). 254–264. 26 indexed citations

12.

Opitz, Isabelle, Alex Soltermann, Hubert Rehrauer, et al.. (2012). Role of Hedgehog Signaling in Malignant Pleural Mesothelioma. Clinical Cancer Research. 18(17). 4646–4656. 55 indexed citations

13.

Steurer, Marc P., Marco P. Zalunardo, Walter Weder, et al.. (2009). Anesthetic-induced Improvement of the Inflammatory Response to One-lung Ventilation. Anesthesiology. 110(6). 1316–1326. 193 indexed citations

14.

İnci, İlhan, André Dutly, Valentin Rousson, Annette Boehler, & Walter Weder. (2001). Trimetazidine protects the energy status after ischemia and reduces reperfusion injury in a rat single lung transplant model. Journal of Thoracic and Cardiovascular Surgery. 122(6). 1155–1161. 27 indexed citations

15.

Cassart, Marie, et al.. (2001). Effects of Lung Volume Reduction Surgery for Emphysema on Diaphragm Dimensions and Configuration. American Journal of Respiratory and Critical Care Medicine. 163(5). 1171–1175. 51 indexed citations

16.

Thurnheer, Robert, Hermann Engel, Walter Weder, et al.. (1999). Role of Lung Perfusion Scintigraphy in Relation to Chest Computed Tomography and Pulmonary Function in the Evaluation of Candidates for Lung Volume Reduction Surgery. American Journal of Respiratory and Critical Care Medicine. 159(1). 301–310. 80 indexed citations

17.

Zaugg, Michael, et al.. (1998). Accidental pleural puncture by a thoracic epidural catheter. Anaesthesia. 53(1). 69–71. 18 indexed citations

18.

Stammberger, Uz, Konrad E. Bloch, Robert Thurnheer, et al.. (1998). Exercise performance and gas exchange after bilateral video-assisted thoracoscopic lung volume reduction for severe emphysema. European Respiratory Journal. 12(4). 785–792. 21 indexed citations

19.

Weder, Walter. (1997). [Video-assisted thoracoscopic surgery--indications, technique and results].. PubMed. 54(9). 533–9. 1 indexed citations

20.

Bloch, Konrad E., Yiming Li, Jinnong Zhang, et al.. (1997). Effect of Surgical Lung Volume Reduction on Breathing Patterns in Severe Pulmonary Emphysema. American Journal of Respiratory and Critical Care Medicine. 156(2). 553–560. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact